IV.接種スケジュール
小児への13価肺炎球菌結合型ワクチン(13-valent pneumococcal conjugate vaccine:PCV13)の接種は,通常2カ月齢でHib(Haemophilus influenza type b)ワクチンなどと同時に,3カ月齢,4カ月齢でHibワクチン,DPT-IPV(diphtheria,pertussis,tetanus,inactivated polio vaccine)ワクチンなどと同時接種されることが多くなってきている.本稿では,PCV13の小児及び成人での利用に加え,PPSV23(23-valent pneumococcal polysaccharide...
Saved in:
Published in | 日本内科学会雑誌 Vol. 104; no. 11; pp. 2330 - 2335 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | Japanese |
Published |
一般社団法人 日本内科学会
2015
|
Subjects | |
Online Access | Get full text |
ISSN | 0021-5384 1883-2083 |
DOI | 10.2169/naika.104.2330 |
Cover
Abstract | 小児への13価肺炎球菌結合型ワクチン(13-valent pneumococcal conjugate vaccine:PCV13)の接種は,通常2カ月齢でHib(Haemophilus influenza type b)ワクチンなどと同時に,3カ月齢,4カ月齢でHibワクチン,DPT-IPV(diphtheria,pertussis,tetanus,inactivated polio vaccine)ワクチンなどと同時接種されることが多くなってきている.本稿では,PCV13の小児及び成人での利用に加え,PPSV23(23-valent pneumococcal polysaccharide vaccine)の接種スケジュールについて概説する. |
---|---|
AbstractList | 小児への13価肺炎球菌結合型ワクチン(13-valent pneumococcal conjugate vaccine:PCV13)の接種は,通常2カ月齢でHib(Haemophilus influenza type b)ワクチンなどと同時に,3カ月齢,4カ月齢でHibワクチン,DPT-IPV(diphtheria,pertussis,tetanus,inactivated polio vaccine)ワクチンなどと同時接種されることが多くなってきている.本稿では,PCV13の小児及び成人での利用に加え,PPSV23(23-valent pneumococcal polysaccharide vaccine)の接種スケジュールについて概説する. |
Author | 多屋, 馨子 新井, 智 |
Author_xml | – sequence: 1 fullname: 新井, 智 organization: 国立感染症研究所感染症疫学センター – sequence: 1 fullname: 多屋, 馨子 organization: 国立感染症研究所感染症疫学センター |
BookMark | eNo9j81Kw0AURgepYKzduvMREufO3EkmSwn-FApu1O1wM040sUZJunGb7PsWBUEouFPo2wzo0lewVnF1Ft_HgbPLBvVD7RjbBx4JiNPDmso7ioBjJKTkWywArWUouJYDFnAuIFRS4w4btW2Zc5Sx0iAxYAfjq6_V_GO--Hxe-u7dd6--e_P9wvcr37_sse2Cpq0b_XHILk-OL7KzcHJ-Os6OJmElRMJDVELoNHfymruCZIpcUyoQCsLcqhg0xYSxVIhg158CUIEWibM2iUGlKIcs-_VW7YxunHlsyntqngw1s9JOndnUmXWdAdjgJ_J_tbfUmIrkNzosVJw |
ContentType | Journal Article |
Copyright | 2015 一般社団法人 日本内科学会 |
Copyright_xml | – notice: 2015 一般社団法人 日本内科学会 |
DOI | 10.2169/naika.104.2330 |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1883-2083 |
EndPage | 2335 |
ExternalDocumentID | article_naika_104_11_104_2330_article_char_ja |
GroupedDBID | ALMA_UNASSIGNED_HOLDINGS DIK F5P JSF OK1 RJT |
ID | FETCH-LOGICAL-j2270-452289be3d0efa39408a9241fa4bc5618a6a4635441c3d0f1451827ecc7615943 |
ISSN | 0021-5384 |
IngestDate | Wed Sep 03 06:28:56 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 11 |
Language | Japanese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-j2270-452289be3d0efa39408a9241fa4bc5618a6a4635441c3d0f1451827ecc7615943 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/naika/104/11/104_2330/_article/-char/ja |
PageCount | 6 |
ParticipantIDs | jstage_primary_article_naika_104_11_104_2330_article_char_ja |
PublicationCentury | 2000 |
PublicationDate | 20150000 |
PublicationDateYYYYMMDD | 2015-01-01 |
PublicationDate_xml | – year: 2015 text: 20150000 |
PublicationDecade | 2010 |
PublicationTitle | 日本内科学会雑誌 |
PublicationTitleAlternate | 日内会誌 |
PublicationYear | 2015 |
Publisher | 一般社団法人 日本内科学会 |
Publisher_xml | – name: 一般社団法人 日本内科学会 |
References | 3) Pilishvili T, et al: Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 201: 32-41, 2010. 6) Jackson LA, et al: Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA 281: 243-248, 1999. 1) Nuorti JP, et al: Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 59: 1-18, 2010. 2) Weinberger DM, et al: Serotype replacement in disease after pneumococcal vaccination. Lancet 378: 1962-1973, 2011. 4) Miller E, et al: Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 11: 760-768, 2011. 5) 庵原俊昭, 他: Hib, 肺炎球菌, HPV及びロタウイルスワクチンの各ワクチンの有効性, 安全性並びにその投与方法に関する基礎的・臨床的研究: 平成25年度総括・分担研究報告書: 厚生労働科学研究費補助金新型インフルエンザ等新興・再興感染症研究事業. 2014. 8) Chiba N, et al: Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan. Epidemiol Infect 138: 61-68, 2010. 10) Shiramoto M, et al: Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine when administered to healthy Japanese adults aged >/=50 years. An open-label trial. Hum Vaccin Immunother 10: 1850-1858, 2014. 9) Goldblatt D, et al: The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 years. Clin Infect Dis 49: 1318-1325, 2009. 7) 常彬, 前川純子: 成人侵襲性肺炎球菌感染症由来株の細菌学的解析, 厚生労働科学研究賞補助金 新型インフルエンザ等新興・再興感染症研究事業 平成26年度総括・分担研究報告書 (研究代表者: 大石和徳). 2015, 63-67. |
References_xml | – reference: 5) 庵原俊昭, 他: Hib, 肺炎球菌, HPV及びロタウイルスワクチンの各ワクチンの有効性, 安全性並びにその投与方法に関する基礎的・臨床的研究: 平成25年度総括・分担研究報告書: 厚生労働科学研究費補助金新型インフルエンザ等新興・再興感染症研究事業. 2014. – reference: 6) Jackson LA, et al: Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA 281: 243-248, 1999. – reference: 9) Goldblatt D, et al: The immunogenicity of 7-valent pneumococcal conjugate vaccine versus 23-valent polysaccharide vaccine in adults aged 50-80 years. Clin Infect Dis 49: 1318-1325, 2009. – reference: 1) Nuorti JP, et al: Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 59: 1-18, 2010. – reference: 2) Weinberger DM, et al: Serotype replacement in disease after pneumococcal vaccination. Lancet 378: 1962-1973, 2011. – reference: 4) Miller E, et al: Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 11: 760-768, 2011. – reference: 8) Chiba N, et al: Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan. Epidemiol Infect 138: 61-68, 2010. – reference: 10) Shiramoto M, et al: Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine when administered to healthy Japanese adults aged >/=50 years. An open-label trial. Hum Vaccin Immunother 10: 1850-1858, 2014. – reference: 3) Pilishvili T, et al: Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 201: 32-41, 2010. – reference: 7) 常彬, 前川純子: 成人侵襲性肺炎球菌感染症由来株の細菌学的解析, 厚生労働科学研究賞補助金 新型インフルエンザ等新興・再興感染症研究事業 平成26年度総括・分担研究報告書 (研究代表者: 大石和徳). 2015, 63-67. |
SSID | ssib043658134 ssj0066765 ssib002821954 ssib005879745 ssib007485360 ssib058493862 ssib000940260 ssib002484664 |
Score | 2.0011299 |
Snippet | 小児への13価肺炎球菌結合型ワクチン(13-valent pneumococcal conjugate vaccine:PCV13)の接種は,通常2カ月齢でHib(Haemophilus influenza type... |
SourceID | jstage |
SourceType | Publisher |
StartPage | 2330 |
SubjectTerms | PCV13 PPSV23 接種スケジュール 肺炎球菌 |
Title | IV.接種スケジュール |
URI | https://www.jstage.jst.go.jp/article/naika/104/11/104_2330/_article/-char/ja |
Volume | 104 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | 日本内科学会雑誌, 2015/11/10, Vol.104(11), pp.2330-2335 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV0_b9QwFLdKkRAL4q-AUtQBTyglie34WWJxjlQtqEhIbdUtSnK54YYrQteF8W7vt6iEhITEBlK_TSQY-Qq8Zyd3OakDLYvP5zw_23mO87Pz_jD2QoVDVUaQBBTXNpBFUQZQiSoQo5GASircAJGh8P77ZPdQvj1Wx2s3NnpaS6fTcrv6fKldyXWkimUoV7KSvYJkF0yxAPMoX0xRwpj-k4z3jni2w9MBh4xnCaVW8UxzC9xiieAQ89R0majLgMsIR-wyyKEtSftglXga7cgwM-AWyRQHbMi3ormJqMS-4TbhmSQ-xvLMcJO6S9gNy2FxDuvYJDwNHa3lRpGAXanhywMDx1I6Top6DaknM9QKDs236MN_dgcW3ljTTS7HHEiDA9sHcL3WxDDNqCp2zQpqMxXUAd-T1L683mD7i34cBbiu-3OL2q_zAAKnko-hs3gR-EDI3YyP-uu6aL8e1d1fddn7J44Sct86Iesv-nq-vay34tO7nTG5I8yREDdi7ofo8-4q2d3lYwT_N2OtI9JXffehh52NJH9wPawFK6ECcC8d9X39KdCmH9pAS0Rqy_pSIBaNlr4CEZgaAcnCFxvpQvtwIO3d9B5QacSvVseLWG6MO5tOK9IBtYO77E67w9qyfnj32Nq4uM9u7bc6JA_Y5t7Rn4uzX2fnv798a2Y_m9n3ZvajmZ8384tm_vUhO9zJDga7QRskJBjHsQ4DiggApqzFMKxHhcCbAoVBWDoqZFnh5gCKpJCIqhH2V0gzosjUEGtcuTSCeSPFI7Y-OZnUj9lWVEsdIrUU2hlwgxoWZY1oTpFXQ108Ya_9wPKP3hNMfiU5Pv2_6hvsNj1N_vjvGVuffjqtNxEQT8vnbmL8BUu0hFU |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IV%EF%BC%8E%E6%8E%A5%E7%A8%AE%E3%82%B9%E3%82%B1%E3%82%B8%E3%83%A5%E3%83%BC%E3%83%AB&rft.jtitle=%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E6%96%B0%E4%BA%95%2C+%E6%99%BA&rft.au=%E5%A4%9A%E5%B1%8B%2C+%E9%A6%A8%E5%AD%90&rft.date=2015&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=0021-5384&rft.eissn=1883-2083&rft.volume=104&rft.issue=11&rft.spage=2330&rft.epage=2335&rft_id=info:doi/10.2169%2Fnaika.104.2330&rft.externalDocID=article_naika_104_11_104_2330_article_char_ja |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5384&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5384&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5384&client=summon |